The Basic Research certificate program is designed to provide non-clinical professionals with the tools to conduct successful multi-disciplinary, non-clinical biopharmaceutical development studies. Upon completion of the curriculum, you will be equipped to adequately assess risk/benefit utilizing key information obtained from pharmacology, toxicology, and pharmacokinetics to identify lead candidates for further pharmaceutical development.
This educational track is designed for professionals working as:
- Chemists
- Biochemists
- Drug Discovery Scientists
- Drug Safety Associates and Managers
- Immunologists
- Pathologists
- Pharmacologists
- Toxicologists
- Virologists
- Clinical Research Assistants and Associates
To earn the certificate, you must complete TWO core courses and TWO elective courses from the list below. Courses must be completed within five years to remain eligible for earning a PERI certificate. Once you have completed the required courses, contact the PERI Registrar for validation, and the Basic Research certificate will be mailed to you. If you have questions about your progress, contact PERI at info@peri.org.
Core Courses
In a blending of online and live learning, this course provides an overview of the process and issues common to all new chemical entity (NCE) development projects, from the research and development stages through product launch and post-marketing safety.
*NOTE: Students may only count Basic Drug Development or Decision Points in Pharmaceutical Development as one of the required core courses.
View Open Course Schedule for Upcoming Basic Drug Development Programs
This fundamental online blended program pairs the essential Pharmacology Online distance education program with weekly webinars, case studies and online discussions to enhance learning and retention of key basic research information.
Related Course: Pharmacology Online Distance Education Program
This course provides the essential foundation for toxicology in the nonclinical development and regulatory approval of drugs and biologics.
Related Course: Pharmacology Online Distance Education Program
This introductory web-based module focuses on the critical decisions that are made throughout the development of a new chemical entity as the process evolves from discovery to first in humans and ultimately to launch.
Course recently revised and refreshed!
*NOTE: Students may only count Basic Drug Development or Decision Points in Pharmaceutical Development as one of the required core courses.
This online course provides an intensive overview of pharmacology, knowledge of which is critical for both drug discovery and development.
Course recently revised and refreshed!
Elective Courses
Gain a broad multidisciplinary understanding of the scientific, management and regulatory decision points in the development of new biologics and biosimilars.
This course provides an overview of human cancer with discussions on specific cancer types, current therapeutics and clinical trial design.
This intermediate course explores the three key phases of clinical development of pharmaceuticals and addresses the skills needed to effectively and safely conduct global clinical trials.
This course focuses on global regulatory requirements required for the management of product safety data from clinical trial and post-market sources.
This course provides an intuitive approach to pharmacokinetic (PK) concepts, using easily understood mathematical and descriptive teaching methods.
Related Course: Pharmacology Online Distance Education Program
This course addresses project management issues and skills needed to wisely choose and effectively develop new therapies in today’s global climate.
This online course will review statistical terminology, provide an understanding of statistics, and explain trial design from a clinician’s viewpoint. Course recently revised and refreshed!
Continuing Education Credits
Pharmaceutical Education & Research Institute, Inc. (PERI) is pleased to make continuing education credit available to you for attendance at this program. To receive credit, you must attend the entire program and submit the Continuing Education Application form directly to a PERI on-site coordinator. Additional $35 fee applies for students who are applying for continuing education credit.
Continuing Medical Education (CME)
PERI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education (CPE)
Pharmaceutical Education & Research Institute, Inc. (PERI) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based CPE Activity.
Ready to Start?
Apply in just two minutes or start searching for courses immediately.
Current Students: Track Progress
Submit your basic contact information to receive a progress update report.